Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With PolyneuropathyDavid Adams, Mónica Freitas, Jonas Wixner et al.|JAMA Neurology|2025Cited by 34
Myocardial Induction of Type 3 Deiodinase in Dilated CardiomyopathyAri J. Wassner, Stephen A. Huang, Ann Marie Zavacki et al.|Thyroid|2017Cited by 14
Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial IschemiaMonique R. Heitmeier, Paul W. Hruz, Maria Payne et al.|Scientific Reports|2018Cited by 11
Abstract 13273: APOLLO-B, a Study of Patisiran in Patients With Transthyretin Cardiac Amyloidosis: Primary Long-Term Results From the Open-Label Extension PeriodRebecca R. Hung, Matthew J. Maurer, Edileide de Barros Correia et al.|Circulation|2023Cited by 6
Evaluation of disease progression in patients with ATTR amyloidosis with cardiomyopathy following treatment with patisiran: post-hoc analysis of the APOLLO-B studyThibaud Damy, Mazen Hanna, Zubair Shah et al.|European Heart Journal|2023Cited by 0